Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-05-22 @ 11:44 AM
Study NCT ID:
NCT06284902
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2024-02-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability Study of Fexofenadine HCl New Formulation Tablet
Sponsor:
Opella Healthcare Group SAS, a Sanofi Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BDR17987
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None